A new publication from the NCD Alliance explains the commonalities in needs and challenges across the different NCD conditions.
-
A key focus of INNODIA is conducting clinical intervention studies to facilitate the development of novel treatments to prevent and cure type 1 diabetes. -
MoU signed to improve access to affordable and high-quality medicines in low- and middle-income countries.
-
IDF is looking for new data sources of diabetes prevalence to generate national, regional and global estimates.
